Trials / Completed
CompletedNCT00570739
Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.
Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, as Initial Therapy in Drug naïve Subjects With Type 2 Diabetes Mellitus, and the Effects of Colesevelam HCl on the Lipid Profile in Subjects With Pre Diabetes
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 502 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This is a 16-week double-blind, placebo-controlled (for colesevelam hydrochloride (HCl)) study in the type 2 diabetic subjects and pre-diabetic subjects. Diabetic participants will also be treated with open label, background,metformin HCl. Two-hundred sixty subjects with type 2 diabetes (T2DM) and 200 pre-diabetic subjects are planned to be be enrolled. Qualified subjects with T2DM will be randomized 1:1 to receive metformin HCl plus colesevelam HCl or metformin HCl plus placebo matching colesevelam HCl. Qualified pre-diabetic subjects will be randomized 1:1 to receive colesevelam HCl or matching placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin HCl and Colesevelam Placebo | One or two Metformin HCl tablets 850 mg (depending on tolerability) and 6 colesevelam 625 mg placebo tablets once daily for 16 weeks |
| DRUG | Metformin HCl tablets and Colesevelam tablets | One or two Metformin HCl tablets 850 mg (depending on tolerability) and 6 colesevelam 625 mg tablets once daily for 16 weeks |
| DRUG | Colesevelam placebo | Six colesevelam 625 mg placebo tablets will be given once a day for 16 weeks |
| DRUG | Colesevelam | Six colesevelam 625 mg tablets will be given once a day for 16 weeks. |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2007-12-11
- Last updated
- 2010-07-27
- Results posted
- 2010-07-13
Locations
31 sites across 4 countries: United States, Colombia, India, Mexico
Source: ClinicalTrials.gov record NCT00570739. Inclusion in this directory is not an endorsement.